Rheumatoid Arthritis Clinical Trial
Official title:
Looking for Biomarkers in Human Joint Fluid Using Metabonomic, Microbiomic and Tribological Analysis
Making the diagnosis underlying a painful, swollen joint currently involves aspiration
followed by numerous microbiological and biochemical laboratory tests. This can be costly,
time consuming and in the case of an acutely swollen joint, lead to a lengthy inpatient
admission. There is an unmet need to provide a quick, easy, reliable dipstick like test to
analyse joint fluid in the community, clinic, or emergency department setting.
The investigators aim to use well established metabonomic techniques to:
1. Analyse fluid from patients with swollen joints
2. Identify potential biomarkers of inflammatory, infective and osteoarthritic causes of
joint swelling
3. Correlate this with lubrication and wear properties of the fluid The long term goal is
to develop time saving, cost effective, non-invasive diagnostic tests to improve
management of a swollen joint. The biomedical research centre at Imperial provides a
unique and unparalleled clinical and scientific environment to conduct this research.
The Imperial College division of Computational and Systems Medicine has an international
reputation in metabonomics and this, together with the high volume of patients with
swollen joints treated at Imperial National Health Service Trust (c1000/yr) ensures that
the study can take place in an environment conductive to success.
Swollen joints represent a diagnostic challenge. Possible diagnoses include: osteoarthritis,
gout, rheumatological disease or infection. Diagnostic methods are limited to microscopy,
microbiology and trace analysis. These methods can be slow, time consuming, expensive and
often inconclusive.
Osteoarthritis varies in the severity of any inflammatory response and subsequent symptoms.
To date no molecular link has been established to explain this ambiguity. Previous studies
have identified metabolites of the inflammatory response but failed to investigate any
correlation with symptoms or response to targeted injections.
Microbial infections of joints are destructive. It typically takes 2-3 days to identify a
causative organism and confirm diagnosis. Recent studies suggest low-level bacterial
colonisation within joints. The investigators aim to analyse the joint fluid for any
bacterial colonisation using enrichment and 16S Polymerase Chain Reaction (PCR) then
correlate the results to the metabolic profile. In addition the investigators aim to seek
metabolites indicative of the presence of a biofilm which, if present severely limits
treatment options.
Metabonomics is the quantitative measurement of the dynamic multiparametric response of a
living system to pathophysiological stimuli or genetic modification. This provides a global
metabolic profile despite a complex biological sample and has proven useful in many fields.
Our hypotheses are:
1. Each pathology will have a unique metabolic profile
2. Inflammatory osteoarthritis will contain a different metabolic profile and potentially
biomarkers to treatment and/or response
3. Specifically the presence and detection of organism sub-type and biofilm biomarkers
4. These profiles can be characterised by analysis of blood, urine and joint fluid
5. This data can be used to generate diagnostic tests that will aid management of a swollen
joint.
6. There will be a correlation between metabolic profile and lubricant properties of the
joint fluid, that can be utilised in future engineering strategies to manage
osteoarthritis.
1. To analyse joint fluid from osteoarthritic joints to identify potential biomarkers of the
disease and further understanding of the cartilage destruction pathways 2. To assess
population variances in joint fluid composition using metabonomics and whether this
composition correlates to arthropathy of joints 3. To study the lubrication and wear
properties of the joint fluid and understand how the metabolic profile influences lubrication
and subsequently joint wear.
4. To study joint fluid using metabonomics to identify biomarkers of bacterial colonisation
in tandem with microbial 16S Polymerase Chain Reaction and genomic sequencing.
Project Timeline:
Phases of the project are to be as follows:
Full research, Site and Ethical Approval: Provisional ethics is already granted. No obstacles
to research and site approval are expected and this should be achieved shortly afterwards.
(success = ethical approval) Expected June 2015
Sample Collection: The investigators aim to recruit 150 patients to the study capturing a
conservative estimate of 10 per week. All orthopaedic patients will be targeted. The majority
are expected to be recruited from the elective theatres. (success = 150 pts recruited) June -
September 2015 (onwards)
Metabonomic Analysis Method Development: Establishing Nuclear Magnetic Resonance (NMR)
methodology for metabolic profiling of synovial fluid as a sample matrix. Method development
of Liquid Chromatography Mass Spectroscopy (LCMS) untargeted and targeted methodology for
synovial fluid (success = achieving robust, sensitive methodology) October 2015
Joint Fluid Tribology: Analysis of the lubricating properties of the joint fluid (success =
150 samples assayed) October - December 2015
Metabonomic Analysis: In order to yield the maximum results the investigators aim to analyse
using NMR screening with untargeted and targeted LCMS analysis. With approximately 150
patients and thus 450 body fluid samples the investigators are estimating an analysis time of
6 months (success = metabolic profiling and targeted analysis) November - April 2016
Microbial Genetic Analysis: PCR and sequencing of the microbial genetic content of the joint
fluid (success = completion in 150 samples) April - June 2016
Collation of results, Analysis and Reporting: Preparation of results for submission to a
journal with an impact factor >10. (success = editorial acceptance of manuscript) July -
October 2016
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |